Silence Therapeutics Stock (NASDAQ: SLN) stock price, news, charts, stock research, profile.
Open | $18.00 |
Close | $18.21 |
Volume / Avg. | 119.69K / 144.48K |
Day Range | 17.55 - 18.62 |
52 Wk Range | 4.84 - 27.72 |
Market Cap | $849.68M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 2.41% |
Days to Cover | 7.55 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Silence Therapeutics (NASDAQ:SLN) through any online brokerage.
Other companies in Silence Therapeutics’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE) and 4D Molecular Therapeutics (NASDAQ:FDMT).
There is no analysis for Silence Therapeutics.
Silence Therapeutics has a consensus price target of $52.80.
The stock price for Silence Therapeutics (NASDAQ: SLN) is $18.21 last updated July 5, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Silence Therapeutics.
Silence Therapeutics’s Q2 earnings are confirmed for Wednesday, August 14, 2024.
There is no upcoming split for Silence Therapeutics.
Silence Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.